The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

44 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.EBI
University of Karachi
Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.EBI
University of Karachi
Biology-oriented drug synthesis (BIODS): In vitroß-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives.EBI
University of Karachi
Dihydropyrimidones: As novel class ofß-glucuronidase inhibitors.EBI
University of Karachi
Thiadiazole derivatives as New Class ofß-glucuronidase inhibitors.EBI
University of Karachi
Synthesis of diethyl 4-substituted-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylates as a new series of inhibitors against yeasta-glucosidase.EBI
University of Karachi
Synthesis andß-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.EBI
University of Karachi
Evaluation of bisindole as potentß-glucuronidase inhibitors: synthesis and in silico based studies.EBI
University of Karachi
Fungal transformation of cedryl acetate anda-glucosidase inhibition assay, quantum mechanical calculations and molecular docking studies of its metabolites.EBI
University of Karachi
3D-QSAR CoMFA studies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents.EBI
University of Karachi
3-Formylchromones: potential antiinflammatory agents.EBI
University of Karachi
Bioactive constituents from Boswellia papyrifera.EBI
University of Karachi
Identification of acridinyl hydrazides as potent aspartic protease inhibitors.EBI
University of Karachi
New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships.EBI
University of Karachi
Methylenebissantin: a rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase.EBI
University of Karachi
1,3,4-Oxadiazole-2(3H)-thione and its analogues: a new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors.EBI
University of Karachi
Microbial transformation and butyrylcholinesterase inhibitory activity of (-)-caryophyllene oxide and its derivatives.EBI
University of Karachi
New bioactive diterpene polyesters from Euphorbia decipiens.EBI
University of Karachi
New triterpenoid alkaloid cholinesterase inhibitors from Buxus hyrcana.EBI
University of Karachi
Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum.EBI
University of Karachi
Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico.EBI
University of Karachi
Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.EBI
University of Karachi
Microwave-Assisted Organic Synthesis, structure-activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors.EBI
University of Karachi
Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking.EBI
University of Karachi
Schiff bases of 3-formylchromone as thymidine phosphorylase inhibitors.EBI
University of Karachi
Biotransformation of (-)-ambrox by cell suspension cultures of Actinidia deliciosa.EBI
University of Karachi
Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.EBI
University of Karachi
Pyridone derivative, pharmaceutical containing the same and methods of use thereofBDB
Kaken Pharmaceutical
Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.BDB
Cairo University
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivativesBDB
Pfizer
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBDB
Janssen Pharmaceutica
PIF-pocket as a target for C. albicans Pkh selective inhibitors.BDB
Universit£Tsklinikum Frankfurt
Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors.BDB
Beckman Research Institute of The City of Hope
Imidazolothiazole compounds and methods of use thereofBDB
Ambit Biosciences
S1P3 receptor inhibitors for treating painBDB
Allergan
Non-amidic linkers with branched termini as CGRP receptor antagonistsBDB
Merck Sharp & Dohme
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.BDB
Centre De Recherches De Croissy
Behaviroal, pharmacological, and molecular characterization of an amphibian cannabinoid receptor.BDB
Oregon State University
Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands.BDB
Washington State University
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.BDB
Smithkline Beecham Pharmaceuticals
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.BDB
Institut De Recherches Servier
7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist.BDB
Otsuka Pharmaceutical
Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors.BDB
Universite De Lyon